SYNOVATE

SYNOVATE_Logo_Tag_RGB - higher res no study

SYNOVATE is a randomized, global Phase 3 trial to evaluate CMB305 immuontherapy in synovial sarcoma patients. www.synovatestudy.com

Immune Design Corp.
Format

JPEG

Downloads